Core Laboratories CLB Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Core Laboratories's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Core Laboratories's additional paid-in capital?
- Core Laboratories (CLB) reported additional paid-in capital of $115.22M in Q1 2026.
- How has Core Laboratories's additional paid-in capital changed year-over-year?
- Core Laboratories's additional paid-in capital increased by 1.5% year-over-year, from $113.57M to $115.22M.
- What is the long-term trend for Core Laboratories's additional paid-in capital?
- Over 3 years (2022 to 2025), Core Laboratories's additional paid-in capital has grown at a 2.5% compound annual growth rate (CAGR), from $102.25M to $110.25M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.